DBD Valuation

Diebold Nixdorf Inc

Add to Watchlist

Advanced Chart

46.450

+1.080(+2.380%)

Overview
Forecast
Valuation

DBD Relative Valuation

DBD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DBD is overvalued; if below, it's undervalued.

Historical Valuation

Diebold Nixdorf Inc (DBD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.52 is considered Undervalued compared with the five-year average of 7.90. The fair price of Diebold Nixdorf Inc (DBD) is between 111.10 to 124.00 according to relative valuation methord. Compared to the current price of 46.45 USD , Diebold Nixdorf Inc is Undervalued By 58.19%.

Relative Value

Fair Zone

111.10-124.00

Current Price：46.45

58.19%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.79

P/B

Median3y

1.23

Median5y

1.23

7.90

FCF Yield

Median3y

-14.35

Median5y

-14.35

Competitors Valuation Multiple

The average P/S ratio for DBD's competitors is 2.12, providing a benchmark for relative valuation. Diebold Nixdorf Inc Corp (DBD) exhibits a P/S ratio of 0.44, which is -79.17% above the industry average. Given its robust revenue growth of -4.62%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap